Related Experiment Video
Updated: Aug 10, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Thalassemia major-- on the verge of bleeding or thrombosis?
Rahul Naithani1, Jagdish Chandra, Shashi Narayan
1Department of Pediatrics, Kalawati Saran Children's Hospital, New Delhi, 110001, India. dr_rahul6@hotmail.com
Insights
Children with beta-thalassemia major show significant hemostatic system alterations, increasing risks for bleeding and future blood clots. Early childhood assessment is crucial for identifying these predisposing factors.
Area of Science:
- Hematology
- Pediatric Medicine
- Thrombosis Research
Background:
- Thrombotic events are a known complication in adult thalassemia patients.
- Understanding early hemostatic changes in children is vital for predicting future risks.
Purpose of the Study:
- To assess hemostatic derangements in polytransfused children with beta-thalassemia major (beta-TM).
- To identify potential predisposing factors for thrombotic and hemorrhagic events in early childhood.
Main Methods:
- Evaluated 54 children with beta-TM and 30 controls.
- Measured complete blood count, coagulation times (PT, aPTT), protein C, protein S, Antithrombin III (AT III), fibrinogen, d-dimer, serum iron, serum ferritin, and liver function tests.
Main Results:
- 33.3% had thrombocytopenia, 40.7% prolonged PT, and 46.3% prolonged aPTT.
- Low levels of Protein C (26.2%), Protein S (28.6%), and AT III (46.8%) were observed.
- High serum ferritin levels correlated with prolonged PT and lower protein S, indicating altered coagulation and iron overload.
Conclusions:
- Polytransfused children with beta-thalassemia exhibit significant hemostatic system alterations.
- These alterations predispose children to both hemorrhagic manifestations and future thromboembolic events.
- Early assessment and management are critical for mitigating risks in pediatric beta-thalassemia.
Unlabelled:
Thrombotic events have been reported in adult thalassemic patients. To investigate this further, we measured hemostatic parameters in thalassemic children to identify possible predisposing factors in early childhood.
Objective:
To assess hemostatic derangements in polytransfused children with beta-thalassemia major (beta-TM).
Methods:
Complete blood count, prothrombin time, activated partial thromboplastin time, protein C, protein S, Antithrombin III (AT III), fibrinogen, d-dimer assay, serum iron, serum ferritin and liver function tests were measured in 54 patients and 30 controls using standard lab methods.
Results:
Sixteen patients exhibited bleeding manifestations. None of the cases had thromboembolic phenomena. The average pretransfusion haemoglobin in the cases studied was 8.45 +/- 1.6 g/dl, thrombocytopenia was seen in 33.3%, prolongation of prothrombin time was seen in 40.7% and prolongation of aPTT was seen in 46.3%. None of our patients had laboratory features of DIC. Protein C was low in 26.2%, protein S in 28.6% and AT III levels in 46.8% of cases. Mean fibrinogen levels and d-dimers were similar in cases and controls. Serum ferritin levels in the patients were high with a mean of 3,709 +/- 1,625 ng/ml. Serum ferritin had a significant positive correlation with PT (r = 0.382) and ALT (r = 0.315) and a significant negative correlation with protein S (r = - 0.376). Prolonged PT correlated with prolonged aPTT, low protein C, low protein S and serum ferritin levels. Protein C had a significant positive correlation with AT III. Low AT III activity correlated positively with age, aspartate transaminase and alanine transaminase. Average hemoglobin maintained correlated negatively with serum ferritin levels (r = - 0.540), and AST (r = - 0.417). Bleeding episodes correlated with age, liver size and number of transfusions.
Conclusion:
Significant alterations in the hemostatic system already exist in polytransfused children with beta-thalassemia that make it a high-risk condition for both hemorrhagic manifestations and future development of thromboembolic events.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management